Ascend Wellness Holdings, Inc. (AAWH) stock
AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.39−0.00 (-0.73%)
Close on Oct 19, 2026Market cap $79.60MP/E –Yield –
Ascend Wellness operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Ascend Wellness's operating cash flow for the twelve months ending Jun 30, 2026 was $17.35M, down 71.5% year over year. For fiscal 2025 it was $38.05M, down 48.1% from the year before. The highest annual figure on record is $75.33M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.05M | -48.1% |
| FY2024 | Dec 31, 2024 | $73.29M | -2.7% |
| FY2023 | Dec 31, 2023 | $75.33M | – |
| FY2022 | Dec 31, 2022 | -$38.36M | – |
| FY2021 | Dec 31, 2021 | -$41.74M | – |
| FY2020 | Dec 31, 2020 | -$6.00M | – |
| FY2019 | Dec 31, 2019 | -$40.93M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.45M | +26.1% |
| Q1 FY2026 | Mar 31, 2026 | -$19.41M | -426.8% |
| Q4 FY2025 | Dec 31, 2025 | $16.32M | -53.6% |
| Q3 FY2025 | Sep 30, 2025 | -$2.00M | -201.6% |
| Q2 FY2025 | Jun 30, 2025 | $17.80M | -44.8% |
| Q1 FY2025 | Mar 31, 2025 | $5.94M | +52.3% |
| Q4 FY2024 | Dec 31, 2024 | $35.17M | +111.0% |
| Q3 FY2024 | Sep 30, 2024 | $1.97M | -92.8% |
| Q2 FY2024 | Jun 30, 2024 | $32.25M | +27.0% |
| Q1 FY2024 | Mar 31, 2024 | $3.90M | -32.5% |
| Q4 FY2023 | Dec 31, 2023 | $16.67M | – |
| Q3 FY2023 | Sep 30, 2023 | $27.49M | – |
| Q2 FY2023 | Jun 30, 2023 | $25.40M | – |
| Q1 FY2023 | Mar 31, 2023 | $5.78M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.07M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.78M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.26M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.25M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.44M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.24M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.23M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.83M | -302.8% |
| Q4 FY2020 | Dec 31, 2020 | -$336.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.23M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.30M | – |
| Q1 FY2020 | Mar 31, 2020 | $3.86M | – |
See a number that looks wrong?